Similar articles

• ACP Journal Club. Pioglitazone was associated with lower risk for adverse cardiovascular events than rosiglitazone in older patients.

  Basu A. Basu A. Ann Intern Med. 2010 Feb 16;152(4):JC-213. doi: 10.7326/0003-4819-152-4-201002160-02013. Ann Intern Med. 2010. PMID: 20157125 No abstract available.
• ACP Journal Club. Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer.

  Hajdenberg J. Hajdenberg J. Ann Intern Med. 2009 Dec 15;151(12):JC6-14. doi: 10.7326/0003-4819-151-12-200912150-02014. Ann Intern Med. 2009. PMID: 20008750 No abstract available.
• ACP Journal Club. Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users.

  Brophy JM. Brophy JM. Ann Intern Med. 2011 Oct 18;155(8):JC4-5. doi: 10.7326/0003-4819-155-8-201110180-02005. Ann Intern Med. 2011. PMID: 22007064 No abstract available.
• ACP Journal Club. Daily multivitamin supplements did not reduce risk for major CV events over > 10 years in men.

  Fairfield KM. Fairfield KM. Ann Intern Med. 2013 Feb 19;158(4):JC8. doi: 10.7326/0003-4819-158-4-201302190-02008. Ann Intern Med. 2013. PMID: 23420255 No abstract available.
• ACP Journal Club. Review: biologic agents increase short-term risk for some adverse events in conditions other than HIV or AIDS.

  Schattner A. Schattner A. Ann Intern Med. 2012 May 15;156(10):JC5-9. doi: 10.7326/0003-4819-156-10-201205150-02009. Ann Intern Med. 2012. PMID: 22586027 No abstract available.